TKO Group Holdings Inc vs State Street SPDR S&P Biotech ETF — how do they compare? TKO Group Holdings Inc trades at $181.83 (market cap $13.70B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: TKO Group Holdings Inc pays a 1.7% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, TKO Group Holdings Inc nearer its low. Which is the better fit depends on your goals.
| TKO | XBI | |
|---|---|---|
Market Cap | $13.70B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $224.96 | $164.28 |
52-Week Low | $155.61 | $85.16 |
Enterprise Value | $17.88B | — |
Dividend Yield | 1.7% | — |
Trailing returns across standard periods
Latest headlines on both assets
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →